KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Bausch Health Companies (BHC) R&D In Process (2016 - 2019)

Bausch Health Companies' R&D In Process history spans 9 years, with the latest figure at $1.0 million for Q1 2019.

  • For Q1 2019, R&D In Process changed 0.0% year-over-year to $1.0 million; the TTM value through Mar 2019 reached $21.5 million, down 4.44%, while the annual FY2018 figure was $1.0 million, 80.0% down from the prior year.
  • R&D In Process for Q1 2019 was $1.0 million at Bausch Health Companies, roughly flat from $1.0 million in the prior quarter.
  • Across five years, R&D In Process topped out at $95.8 million in Q3 2015 and bottomed at -$20.0 million in Q4 2016.
  • The 4-year median for R&D In Process is $1.0 million (2016), against an average of $14.8 million.
  • The largest annual shift saw R&D In Process skyrocketed 381.41% in 2015 before it plummeted 852.38% in 2016.
  • A 4-year view of R&D In Process shows it stood at -$2.1 million in 2015, then tumbled by 852.38% to -$20.0 million in 2016, then soared by 105.0% to $1.0 million in 2018, then changed by 0.0% to $1.0 million in 2019.
  • Per Business Quant, the three most recent readings for BHC's R&D In Process are $1.0 million (Q1 2019), $1.0 million (Q1 2018), and -$20.0 million (Q4 2016).